 Home > Medical News > Latest Medical News > Yingli Pharmaceutical's KRAS inhibitor is approved for clinical use in the U.S.

Yingli Pharmaceutical's KRAS inhibitor is approved for clinical use in the U.S.

 Last Update: 2021-08-15
 Source: Internet
 Author: User

Tags

fda drug approval process

difference vitro vivo

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Transfer from | Pharmaceutical Mission Hills

On July 16, Yingli Pharmaceuticals announced that its self-developed new KRAS G12C inhibitor YL-15293 was approved by the US FDA for clinical trials.

KRAS protein belongs to the GTPase family.

Studies have shown that KRAS gene mutations exist in a variety of tumors, among which G12C mutations are mainly found in lung cancer, colorectal cancer and pancreatic cancer.

According to the press release, YL-15293 is a KRAS small molecule inhibitor independently developed by Yingli Pharmaceutical

Reference materials:

[1] Yingli Pharmaceutical YL-15293 obtained clinical trial approval from the US FDA.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.